Medicare and Medicaid move toward covering Ozempic and other weight loss drugs

Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the weight loss drugs, according to a new report.

State Medicaid programs and Medicare Part D plans could soon voluntarily choose to cover these drugs for “weight management,” The Washington Post reports, citing internal documents from the Centers for Medicare and Medicaid.